NGS

Molecular Genetic

Molecular Genetic Of Infectious

Cytogenetics

Our Services

Focus

Hereditary Cancer

Bion Medical Genetic Laboratory’s Focus and Comprehensive Cancer Panels give the physician the ability to easily select the right test for their patient that is most relevant to their medical care. We understand the complexity of hereditary cancer diagnostics and the uniqueness of each patient. Explore the best option for your patient needs.

For more information contact us.

Focus Cancer

Bion Medical Genetic Laboratory’s Focus Cancer Panels target 30 genes associated with high/moderate risk for hereditary cancer syndromes and established clinical management. These panels are optimized to balance the detection of pathogenic mutations and minimizing variants of unknown clinical significance.

For more information contact us

Comprehensive Cancer

Bion Medical Genetic Laboratory Comprehensive Cancer Panels cover 127 genes associated with potential risk for hereditary cancer syndromes. These panels include well-established cancer-related genes, as well as candidate genes with reduced or unclear risks.

For more information contact us

Learn More

COMPREHENSIVE

Events and News

Risk Factors for Early Breast Cancer
September 26, 2023

Certain risk factors increase the likelihood of women developing breast cancer at a younger age ...

Read More
The NCCN Guidelines for Colorectal Cancer Screening and Diagnosis
September 9, 2023

The NCCN Guidelines for Colorectal Cancer Screening and Diagnosis have been developed to facilitate clinical decision making. This manuscript discusses the diagnostic evaluation of individuals with suspected colon cancer due to either abnormal imaging and/or physical findings. For colorectal cancer screening recommendations ...

Read More
Guidelines for Breast Cancer Screening and Diagnosis(NCCN Guidelines®)
July 31, 2023

The NCCN Guidelines for Breast Cancer Screening and Diagnosis have been developed to facilitate clinical decision making. This manuscript discusses the diagnostic evaluation of individuals with suspected breast cancer due to either abnormal imaging and/or physical findings. For breast cancer screening recommendations ...

Read More
Read More

Videos

slide2
slide3
slide4
slide5
slide6
slide7
slide8